|
|
Article: Solucient: Hospital Use of Drug-Eluting Stents Surpasses Bare Metal Stents; NE Hospitals Lead Nation In Delivery of Procedure
- Article from:
- U.S. Newswire
- Article date:
- March 4, 2004
CopyrightCopyright 2004 U.S. Newswire. Provided by ProQuest LLC. (Hide copyright information)
|
EVANSTON, Ill., March 4 /U.S. Newswire/ -- Hospital use of drug-
eluting stents surpassed that of bare-metal stents six months after
the new type of stent was approved by the Food and Drug
Administration (FDA) in April 2003, according to groundbreaking
market place research of this technology released today by
Solucient(r). Key findings appear in the March 4, 2004 edition of USA
Today.
A drug-eluting stent is a tiny metal scaffold used to prop-up
arteries following clearing procedures. The scaffold is coated with a
tiny amount of a drug that slowly seeps into surrounding tissue and
prevents scarring that can reclog a treated vessel. Overall, drug-
eluting coronary artery stent insertions ...